Fierce Biotech Names Proxygen a “Fierce 15” Biotech Company of 2023

VIENNA, Austria, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced that Fierce Biotech has named it as one of 2023’s “Fierce 15” biotechnology companies. The annual special report features the most innovative and promising early-stage biotechnology companies in the industry. “It is an incredible honor to be recognized as one of the Fierce 15 biotech companies for 2023,” said Bernd Boidol, Ph.D., chief executive offi

Jacob Perrett on LinkedIn: What does July's biotech funding reveal

Jacob Perrett posted on LinkedIn

Jacob Perrett on LinkedIn: What does July's biotech funding reveal

Proxygen (@ProxygenTx) / X

见时知几：2023年Fierce15药企预示着哪些投资趋势- 知乎

Fierce Life Sciences Events on LinkedIn: There's still time to

Mark Federici on LinkedIn: Fierce Biotech Names Proxygen a “Fierce

Fierce Biotech on LinkedIn: Takeda bets $4B upfront on Nimbus

Fierce Biotech Names Proxygen a “Fierce 15” Biotech Company of 2023

Jacob Perrett on LinkedIn: VC funding update: Which Boston-area